← Back to Search

Other

Active first for Bipolar Disorder (LFMSBioMGeri Trial)

N/A

Waitlist Available

Led By Brent P Forester, MD

Research Sponsored by Mclean Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up resting state functional magnetic resonance imaging data are acquired 4 times, twice within one hour during imaging visit 1 and twice within one hour during imaging visit 2 which occurs at least two weeks later.

Awards & highlights

LFMSBioMGeri Trial Summary

This trial assesses the effect of Low Field Magnetic Stimulation on brain function in elderly people with bipolar depression.

Eligible Conditions

Bipolar Disorder
Depression, Bipolar Disorder

LFMSBioMGeri Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ resting state magnetic resonance spectroscopic data are acquired 4 times, twice within one hour during imaging visit 1 and twice within one hour during imaging visit 2 which occurs at least two weeks later.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~resting state magnetic resonance spectroscopic data are acquired 4 times, twice within one hour during imaging visit 1 and twice within one hour during imaging visit 2 which occurs at least two weeks later.

This trial's timeline: 3 weeks for screening, Varies for treatment, and resting state magnetic resonance spectroscopic data are acquired 4 times, twice within one hour during imaging visit 1 and twice within one hour during imaging visit 2 which occurs at least two weeks later. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in resting state brain activity measured by functional Magnetic Resonance Imaging.

Secondary outcome measures

Change in resting state Gamma-aminobutyric acid concentration measured by Magnetic Resonance Spectroscopy.

LFMSBioMGeri Trial Design

2Treatment groups

Experimental Treatment

Group I: Sham firstExperimental Treatment1 Intervention

Subjects receive sham Low Field Magnetic Stimulation in the first imaging visit and active in the second.

Group II: Active firstExperimental Treatment1 Intervention

Subjects receive active Low Field Magnetic Stimulation in the first imaging visit and sham in the second.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Low Field Magnetic Stimulation

2013

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mclean HospitalLead Sponsor

212 Previous Clinical Trials

21,554 Total Patients Enrolled

34 Trials studying Bipolar Disorder

2,142 Patients Enrolled for Bipolar Disorder

Brent P Forester, MDPrincipal InvestigatorMclean Hospital

4 Previous Clinical Trials

134 Total Patients Enrolled

2 Trials studying Bipolar Disorder

111 Patients Enrolled for Bipolar Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are taking part in this clinical experiment?

"Affirmative. According to the information hosted on clinicaltrials.gov, this clinical trial is currently enrolling candidates. It was first posted in May of 2018 and it has been recently edited in November 2022. The goal for this study is recruiting 40 patients from a single site."

Answered by AI

Is this research venture currently enrolling participants?

"Clinicaltrials.gov reports that this clinical trial is actively recruiting patients, with the initial posting occuring on May 29th 2018 and an edited version appearing as recently as November 15th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

Brent Forester 2018. "Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03484494.